Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 150.0 | 85 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 11.0 | 65 | |
RA2159 | PI103 | 0.1 | uM | 3 | IP-10 | 11.0 | 55 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 97.0 | 74 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 235.0 | 78 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 404.5 | 82 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 211.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 13.0 | 69 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 66.0 | 76 | |
N2586 | PI103 | 0.1 | uM | 3 | IP-10 | 9.0 | 102 | ||||
0 | IP-10 | 10.5 | 58 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IP-10 | 3249.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 3847.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 1325.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 647.0 | 88 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 906.0 | 84 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 21.5 | 76 | |
RA2159 | EO1428 | 1.0 | uM | 3 | IP-10 | 10.0 | 63 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | IP-10 | 966.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 1249.0 | 63 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 2039.5 | 84 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 1279.0 | 64 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 14.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IP-10 | 597.0 | 77 | |
N2586 | EO1428 | 1.0 | uM | 3 | IP-10 | 10.0 | 68 |